Clinical Trial Update: EVL Plus Drug to Prevent Variceal Rebleeding [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating endoscopic variceal ligation (EVL) plus an additional drug to prevent variceal rebleeding has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Variceal Bleeding

Drugs mentioned

• EVL Plus Drug

Snippet

Sponsor: National Science and Technology Council, Taiwan | Conditions: Bleeding | Phase 4 | Status: TERMINATED